Anti-ox40 antibodies and methods of using the same
AssigneeBoard of Regents, The University of Texas System
InventorsYong-Jun Liu, Kui Shin Voo, Laura Bover, Naoya Tsurushita, J. Yun Tso, Shankar Kumar
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoard of Regents, The University of Texas System
InventorsYong-Jun Liu, Kui Shin Voo, Laura Bover, Naoya Tsurushita, J. Yun Tso, Shankar Kumar
Estimating the term…
Human antibodies, preferably recombinant human antibodies, both humanized and chimeric, which specifically bind to human OX40 are disclosed. Preferred antibodies have high affinity for OX40 receptor and activate the receptor in vitro and in vivo. The antibody can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, are useful for modulating receptor activity, e.g., in a human subject suffering from a disorder in which OX40 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies are provided, and methods of synthesizing the recombinant human antibodies, are also provided.
-19. (canceled)
An isolated antibody that binds to OX40 Receptor protein, comprising:
An isolated antibody that binds OX40R protein comprising a heavy chain variable region comprising the amino acid sequence of:
The isolated antibody of claim 1, wherein the antibody further comprises an Fc with at least one mutation that disrupts binding of Fc to FcR-bearing cells.
Dependencies are inferred from the claim text.